Johnson & Johnson is putting its stroke care business up for sale as the company aims to reorganize and rebuild its medtech unit, the Financial Times reports.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Genmab upgraded to Neutral from Underperform at Exane BNP Paribas
- M&A News: Novartis Seals $3.1B Deal to Acquire Anthos
- Largest borrow rate increases among liquid names
- Trump Trade: President advocates to close carried interest tax loophole
- White House readying order to fire thousands of federal health workers, WSJ says